Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-07-27
2000-09-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540552, A61K 3155, C07D28110, C07D41712
Patent
active
061143227
ABSTRACT:
The present invention is concerned with new hypolipidemic compounds, with processes and novel intermediates for their preparation, with pharmaceutical compositions containing them and with their use in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions, such as atherosclerosis.
Compounds of the formula (I): ##STR1## wherein R.sup.1 to R.sup.10 and X are as defined in the Specification and useful as hypolipidemic compounds.
REFERENCES:
patent: 5580866 (1996-12-01), Housley et al.
patent: 5663165 (1997-09-01), Brieaddy et al.
patent: 5723458 (1998-03-01), Brieaddy et al.
patent: 6020330 (2000-02-01), Enhsen
Grundy, "Cholesterol and Coronary Heart Disease," JAMA, vol. 256, No. 20, pp. 2849-2858, Nov. 28, 1986.
P. Tyle, Review, "Iontophoretic Devices for Drug Delivery," Phaarmaceutical Research, vol. 3, No.6, pp. 318-326, 1986.
Enhsen Alfons
Falk Eugen
Glombik Heiner
Stengelin Siegfried
Hoechst Aktiengesellschaft
Raymond Richard L.
Sripada Pavanaram K
LandOfFree
Hypolipidemic 1,4-benzothiazepine-1,1-dioxides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypolipidemic 1,4-benzothiazepine-1,1-dioxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypolipidemic 1,4-benzothiazepine-1,1-dioxides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212299